Literature DB >> 32616897

Cervinomycins C1-4 with cytotoxic and antibacterial activity from Streptomyces sp. CPCC 204980.

Xiaowen Hu1, Wei Sun1, Shufen Li1, LinLi Li1, Liyan Yu1, Hongyu Liu1, Xuefu You1, Bingya Jiang2, Linzhuan Wu3.   

Abstract

Polycyclic xanthones are secondary metabolites from actinomycetes and cervinomycin A and B are bioactive 26-membered polycyclic xanthones from Streptomyces sp. CPCC 204980. Herein, we report cervinomycins C1-4 (1-4) from the same strain. The structures of 1-4 were determined by 1D- and 2D-NMR, or single-crystal X-ray diffraction. Compounds 1-4 feature the open or loss of A (oxazolidine) ring in their angular polycyclic framework compared with cervinomycin B. Compounds 1-4 showed potent cytotoxicity against human cancer cell lines HCT116 and BxPC-3, with IC50 at 0.9-801.0 nM and strong anti-Gram-positive bacterial activity.

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 32616897     DOI: 10.1038/s41429-020-0342-1

Source DB:  PubMed          Journal:  J Antibiot (Tokyo)        ISSN: 0021-8820            Impact factor:   2.649


  9 in total

1.  A Multifunctional Monooxygenase XanO4 Catalyzes Xanthone Formation in Xantholipin Biosynthesis via a Cryptic Demethoxylation.

Authors:  Lingxin Kong; Weike Zhang; Yit Heng Chooi; Lu Wang; Bo Cao; Zixin Deng; Yiwen Chu; Delin You
Journal:  Cell Chem Biol       Date:  2016-04-21       Impact factor: 8.116

2.  Unveiling the post-PKS redox tailoring steps in biosynthesis of the type II polyketide antitumor antibiotic xantholipin.

Authors:  Weike Zhang; Lu Wang; Lingxin Kong; Tao Wang; Yiwen Chu; Zixin Deng; Delin You
Journal:  Chem Biol       Date:  2012-03-23

3.  Cytotoxic and Antibacterial Cervinomycins B1-4 from a Streptomyces Species.

Authors:  Xiaowen Hu; Xinxin Hu; Xiaomin Hu; Shufen Li; LinLi Li; Liyan Yu; Hongyu Liu; Xuefu You; Zhen Wang; Li Li; Beibei Yang; Bingya Jiang; Linzhuan Wu
Journal:  J Nat Prod       Date:  2019-08-05       Impact factor: 4.050

4.  Isolation of the lysolipin gene cluster of Streptomyces tendae Tü 4042.

Authors:  Patricio Lopez; Andreas Hornung; Katrin Welzel; Claudia Unsin; Wolfgang Wohlleben; Tilmann Weber; Stefan Pelzer
Journal:  Gene       Date:  2010-04-25       Impact factor: 3.688

5.  Kibdelones: novel anticancer polyketides from a rare Australian actinomycete.

Authors:  Ranjala Ratnayake; Ernest Lacey; Shaun Tennant; Jennifer H Gill; Robert J Capon
Journal:  Chemistry       Date:  2007       Impact factor: 5.236

6.  [Metabolic products of microorganisms, 149. Lysolipin I, a new antibiotic from streptomyces violaceoniger (author's transl)].

Authors:  H Drautz; W Keller-Schierlein; H Zähner
Journal:  Arch Microbiol       Date:  1975-12-31       Impact factor: 2.552

7.  Synthesis and Biological Evaluation of Kibdelone C and Its Simplified Derivatives.

Authors:  Janjira Rujirawanich; Soyeon Kim; Ai-Jun Ma; John R Butler; Yizhong Wang; Chao Wang; Michael Rosen; Bruce Posner; Deepak Nijhawan; Joseph M Ready
Journal:  J Am Chem Soc       Date:  2016-08-09       Impact factor: 15.419

Review 8.  Polycyclic xanthone natural products: structure, biological activity and chemical synthesis.

Authors:  Dana K Winter; David L Sloman; John A Porco
Journal:  Nat Prod Rep       Date:  2013-01-21       Impact factor: 13.423

9.  Arixanthomycins A-C: Phylogeny-guided discovery of biologically active eDNA-derived pentangular polyphenols.

Authors:  Hahk-Soo Kang; Sean F Brady
Journal:  ACS Chem Biol       Date:  2014-04-30       Impact factor: 5.100

  9 in total
  3 in total

1.  Discovery, Bioactivity Evaluation, Biosynthetic Gene Cluster Identification, and Heterologous Expression of Novel Albofungin Derivatives.

Authors:  Weiyi She; Wenkang Ye; Aifang Cheng; Xin Liu; Jianwei Tang; Yi Lan; Feng Chen; Pei-Yuan Qian
Journal:  Front Microbiol       Date:  2021-02-01       Impact factor: 5.640

Review 2.  Natural Products from Actinobacteria as a Potential Source of New Therapies Against Colorectal Cancer: A Review.

Authors:  Yadollah Bahrami; Sasan Bouk; Elham Kakaei; Mohammad Taheri
Journal:  Front Pharmacol       Date:  2022-07-11       Impact factor: 5.988

Review 3.  Isolation, Biosynthesis, and Biological Activity of Polycyclic Xanthones From Actinomycetes.

Authors:  Hui-Qing Yu; Gang Li; Hong-Xiang Lou
Journal:  Front Microbiol       Date:  2022-07-13       Impact factor: 6.064

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.